Canaccord analyst Matt Bottomley lowered the firm’s price target on Curaleaf (CURLF) to C$7.25 from C$8.50 and keeps a Buy rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CURLF:
- Curaleaf downgraded to Market Perform from Speculative Buy at Cormark
- Curaleaf price target lowered to C$6.50 from C$11 at Alliance Global Partners
- Curaleaf Holdings Reports Q3 2024 Results
- Curaleaf Holdings Reports Steady Growth Amid Challenges
- Rising High: RIV Capital provides update on revenue, synergy realization